BackCell Source Overview

Cell Source Current Cash

Track Cell Source's current cash ($75K) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$74631.00
↑ 236.13% YoYΔ $52428.00 vs prior year quarter

Peer trimmed avg / median

Loading

Cell Source Current Cash History

Loading

Cell Source vs. peers: Current Cash Comparison

Loading

Cell Source Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Cell Source (CLCS) FAQ

The latest current cash for CLCS is $75K as of December 2024. That compares with $22K in the prior-year period — up 236.1% year over year. Investors often review this figure alongside Cell Source's historical trend and sector peers before judging valuation or financial health.

Over the past year, CLCS's current cash moved from $22K to $75K — a 236.1% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Cell Source's operating scale or balance-sheet position.

A current cash figure of $75K for CLCS is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting CLCS's current cash ($75K), review year-over-year change from $22K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Cell Source's current cash against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.